Management of Group B Streptococcus Necrotizing Fasciitis Secondary to Puncture Wound in Diabetic Patient Using Xenograft* Therapy

Authors

Nikita V. Gambhir, University of Texas Health Science - San AntonioFollow
Heather V. Tran, University of Texas Health Science - San AntonioFollow
Stephanie N. Campbell, University of Texas Health Science - San AntonioFollow

Document Type

Poster

Publication Date

Fall 11-2024

Abstract

Necrotizing soft tissue infection (NSTI) is a rapidly progressive skin and soft tissue infection that primarily affects deeper layers of adipose tissue, fascia and muscle. Once a patient becomes symptomatic, the disease typically progresses within hours. The standard treatment consists of broad-spectrum IV antibiotics, serial debridement and supportive care. However, long-term goals should include prevention of atherosclerotic disease, cardiovascular and cerebrovascular events, and ultimately, a reduction in mortality rates. Following debridement for NSTI, it is not uncommon for patients to require multiple surgeries and secondary wound healing given the extent of soft tissue loss.

Recommended Citation

Gambhir, Nikita V.; Tran, Heather V.; and Campbell, Stephanie N., "Management of Group B Streptococcus Necrotizing Fasciitis Secondary to Puncture Wound in Diabetic Patient Using Xenograft* Therapy" (2024). School of Podiatric Medicine Publications and Presentations. 102.
https://scholarworks.utrgv.edu/sopm_pub/102

ORCID

0000-0002-4425-4921

Academic Level

faculty